
Organization (Academic)
University of Houston System
ClinicalTrials.gov lists University of Houston System as lead sponsor of 103 trials, counting the companies grouped under it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Rows recorded per section (log scale)
16 sections measured, none recorded
Logo University of Houston System, via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.
This page covers University of Houston System and 2 companies grouped under it: 103 lead-sponsored trials (0 its own, 103 in the grouped companies) and 4 legal-entity registrations (2 its own, 2 in the grouped companies).
Companies grouped under this page (2)
Shown in this order: most lead trials first.
| Company | Lead trials | Legal entities |
|---|---|---|
| University of Houston | 101 | 1 |
| University of Houston - Downtown | 2 | 1 |
Disease areas (84)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Substance-Related Disorders | 18 |
| Obesity | 16 |
| Anxiety Disorders | 13 |
| Pediatric Obesity | 9 |
| Stroke | 8 |
Showing 5 of 84 disease areas.
Journals published in (280)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Optometry and vision science : official publication of the American Academy of Optometry | 12 |
| Investigative ophthalmology & visual science | 11 |
| Addictive behaviors | 10 |
| Journal of consulting and clinical psychology | 10 |
| Contemporary clinical trials | 8 |
Showing 5 of 280 journals.
US granted patents (1)
Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.
| US patents granted | Granted in the last 5 years | Most recent grant |
|---|---|---|
| 554 | 131 | 2025-12-23 |
Financing and grant events (547)
Shown in this order: most recent first.
| Date | Round type | Amount (USD) | Source |
|---|---|---|---|
| 2026-05-04 | NIH grant | 1,302,579 | Reporter |
| 2025-09-23 | NIH grant | 431,750 | Reporter |
| 2025-09-19 | NIH grant | 706,950 | Reporter |
| 2025-09-15 | NIH grant | 175,017 | Reporter |
| 2025-09-15 | NIH grant | 365,339 | Reporter |
Showing 5 of 547 events.
Organization relationships (25)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Government of the United States of America | Co sponsors trial with | 4 |
| UPMC Health System | Co sponsors trial with | 1 |
| University of Amsterdam | Co sponsors trial with | 1 |
| American Diabetes Association | Co sponsors trial with | 1 |
| University of California System | Co sponsors trial with | 1 |
Showing 5 of 25 relationships.
Latest dated events (1,269)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2027-08 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2027-04-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-10-30 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-09-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-06-30 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 1,269 events.
Biomarkers this organization publishes on (287)
Shown in this order: most publications first.
Showing 5 of 287 biomarkers.
Not on this page
Checked, with nothing recorded for this organization: related companies not grouped here, trials by start year as sponsor or collaborator, active development programs, approved assets, sponsor delivery record, sec-reported annual financials, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, and biomarker capability evidence.